175 related articles for article (PubMed ID: 3309198)
1. Long-term evaluation of a CNS prophylaxis trial--treatment comparisons and outcome after CNS relapse in childhood ALL: a report from the Childrens Cancer Study Group.
Ortega JA; Nesbit ME; Sather HN; Robison LL; D'Angio GJ; Hammond GD
J Clin Oncol; 1987 Oct; 5(10):1646-54. PubMed ID: 3309198
[TBL] [Abstract][Full Text] [Related]
2. Failed central nervous system prophylaxis in children with acute lymphoblastic leukaemia: treatment and outcome.
Pinkerton CR; Chessells JM
Br J Haematol; 1984 Aug; 57(4):553-61. PubMed ID: 6589013
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system (CNS) prophylaxis in children with low risk acute lymphoblastic leukemia (ALL).
Littman P; Coccia P; Bleyer WA; Lukens J; Siegel S; Miller D; Sather H; Hammond D
Int J Radiat Oncol Biol Phys; 1987 Oct; 13(10):1443-9. PubMed ID: 3305443
[TBL] [Abstract][Full Text] [Related]
4. Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report.
Tubergen DG; Gilchrist GS; O'Brien RT; Coccia PF; Sather HN; Waskerwitz MJ; Hammond GD
J Clin Oncol; 1993 Mar; 11(3):520-6. PubMed ID: 8445427
[TBL] [Abstract][Full Text] [Related]
5. Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen.
Bleyer WA; Coccia PF; Sather HN; Level C; Lukens J; Niebrugge DJ; Siegel S; Littman PS; Leikin SL; Miller DR
J Clin Oncol; 1983 May; 1(5):317-25. PubMed ID: 6366138
[TBL] [Abstract][Full Text] [Related]
6. Therapy of CNS leukemia with intraventricular chemotherapy and low-dose neuraxis radiotherapy.
Steinherz P; Jereb B; Galicich J
J Clin Oncol; 1985 Sep; 3(9):1217-26. PubMed ID: 3861774
[TBL] [Abstract][Full Text] [Related]
7. Comparison of central nervous system prophylaxis with cranial radiation and intrathecal methotrexate versus intrathecal methotrexate alone in acute lymphoblastic leukemia.
Muriel FS; Svarch E; Pavlovsky S; Eppinger-Helft M; Braier J; Vergara B; Garay G; Kvicala R; Divito JM; Failace R; Dibar E; Jimenez E
Blood; 1983 Aug; 62(2):241-50. PubMed ID: 6575836
[TBL] [Abstract][Full Text] [Related]
8. Outcome following late marrow relapse in childhood acute lymphoblastic leukemia.
Chessells J; Leiper A; Rogers D
J Clin Oncol; 1984 Oct; 2(10):1088-91. PubMed ID: 6593434
[TBL] [Abstract][Full Text] [Related]
9. Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukaemia: comparison of 1800 rad and 2400 rad. A report for Children's Cancer Study Group.
Nesbit ME; Sather HN; Robison LL; Ortega J; Littman PS; D'Angio GJ; Hammond GD
Lancet; 1981 Feb; 1(8218):461-6. PubMed ID: 6110090
[TBL] [Abstract][Full Text] [Related]
10. Treatment of meningeal relapse in childhood acute lymphoblastic leukemia. I. Results of craniospinal irradiation.
Kun LE; Camitta BM; Mulhern RK; Lauer SJ; Kline RW; Casper JT; Kamen BA; Kaplan BM; Barber SW
J Clin Oncol; 1984 May; 2(5):359-64. PubMed ID: 6587015
[TBL] [Abstract][Full Text] [Related]
11. Effect of isolated central nervous system leukaemia on bone marrow remission and survival in childhood acute lymphoblastic leukaemia. A report for Children's Cancer Study Group.
Lancet; 1981 Jun; 1(8235):1386-9. PubMed ID: 6113351
[TBL] [Abstract][Full Text] [Related]
12. Remission maintenance of adult acute lymphoblastic leukemia.
Armitage JO; Burns CP
Med Pediatr Oncol; 1977; 3(1):53-8. PubMed ID: 264999
[TBL] [Abstract][Full Text] [Related]
13. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
Kumar P; Kun LE; Hustu HO; Mulhern RK; Hancock ML; Coffey D; Rivera GK
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):477-83. PubMed ID: 7852109
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acute lymphoblastic leukemia in childreq with "prophylactic" intrathecal methotrexate and intensive systemic chemotherapy.
Haghbin M; Tan CT; Clarkson BD; Miké V; Burchenal JH; Murphy ML
Cancer Res; 1975 Mar; 35(3):807-11. PubMed ID: 1054287
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system treatment in childhood acute lymphoblastic leukemia. Long-term follow-up of patients diagnosed between 1973 and 1985.
Gelber RD; Sallan SE; Cohen HJ; Donnelly M; Dalton V; Tobia F; Clavell LA; Tarbell NJ
Cancer; 1993 Jul; 72(1):261-70. PubMed ID: 8508416
[TBL] [Abstract][Full Text] [Related]
16. Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study Group.
Bleyer WA; Sather HN; Nickerson HJ; Coccia PF; Finklestein JZ; Miller DR; Littman PS; Lukens JN; Siegel SE; Hammond GD
J Clin Oncol; 1991 Jun; 9(6):1012-21. PubMed ID: 2033414
[TBL] [Abstract][Full Text] [Related]
17. [Results of preventive management of the central nervous system in 275 children with acute lymphoblastic leukemia].
Henze G; Langermann HJ; Brämswig J; Schellong G; Ludwig R; Riehm H
Klin Padiatr; 1983; 195(3):168-75. PubMed ID: 6576204
[TBL] [Abstract][Full Text] [Related]
18. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
Lange BJ; Blatt J; Sather HN; Meadows AT
Med Pediatr Oncol; 1996 Jul; 27(1):15-20. PubMed ID: 8614385
[TBL] [Abstract][Full Text] [Related]
20. Second central nervous system prophylaxis in children with acute lymphoblastic leukemia who relapse after elective cessation of therapy.
Rivera G; George SL; Bowman WP; Kalwinsky D; Ochs J; Dahl GV; Hustu HO; Simone JV
J Clin Oncol; 1983 Aug; 1(8):471-6. PubMed ID: 6583322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
